Follow
Anthony D. Ho
Anthony D. Ho
Univ. Heidelberg (1998 - pres.), Univ. California, San Diego (UCSD, 1992-1998), Univ. Ottawa (1990
Verified email at urz.uni-heidelberg.de - Homepage
Title
Cited by
Cited by
Year
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
P McLaughlin, AJ Grillo-Lopez, BK Link, R Levy, MS Czuczman, ...
Journal of clinical oncology 16 (8), 2825-2833, 1998
36351998
Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood
W Wagner, F Wein, A Seckinger, M Frankhauser, U Wirkner, U Krause, ...
Experimental hematology 33 (11), 1402-1416, 2005
17362005
Replicative senescence of mesenchymal stem cells: a continuous and organized process
W Wagner, P Horn, M Castoldi, A Diehlmann, S Bork, R Saffrich, V Benes, ...
PloS one 3 (5), e2213, 2008
13032008
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
M Pfreundschuh, J Schubert, M Ziepert, R Schmits, M Mohren, ...
The lancet oncology 9 (2), 105-116, 2008
12872008
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma
A Engert, A Plütschow, HT Eich, A Lohri, B Dörken, P Borchmann, ...
New England Journal of Medicine 363 (7), 640-652, 2010
11032010
Human haematopoietic stem cell lineage commitment is a continuous process
L Velten, SF Haas, S Raffel, S Blaszkiewicz, S Islam, BP Hennig, C Hirche, ...
Nature cell biology 19 (4), 271-281, 2017
9542017
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial
A Engert, H Haverkamp, C Kobe, J Markova, C Renner, A Ho, J Zijlstra, ...
The Lancet 379 (9828), 1791-1799, 2012
7562012
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma …
N Schmitz, L Trümper, M Ziepert, M Nickelsen, AD Ho, B Metzner, N Peter, ...
Blood, The Journal of the American Society of Hematology 116 (18), 3418-3425, 2010
6932010
Aging and replicative senescence have related effects on human stem and progenitor cells
W Wagner, S Bork, P Horn, D Krunic, T Walenda, A Diehlmann, V Benes, ...
PloS one 4 (6), e5846, 2009
5492009
Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin’s lymphoma: final analysis of the German Hodgkin Study Group …
HT Eich, V Diehl, H Görgen, T Pabst, J Markova, J Debus, A Ho, B Dörken, ...
J Clin Oncol 28 (27), 4199-4206, 2010
5252010
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma
BM Beckermann, G Kallifatidis, A Groth, D Frommhold, A Apel, J Mattern, ...
British journal of cancer 99 (4), 622-631, 2008
5022008
DNA methylation pattern changes upon long‐term culture and aging of human mesenchymal stromal cells
S Bork, S Pfister, H Witt, P Horn, B Korn, AD Ho, W Wagner
Aging cell 9 (1), 54-63, 2010
4922010
Rituximab therapy of patients with B-cell chronic lymphocytic leukemia
D Huhn, C von Schilling, M Wilhelm, AD Ho, M Hallek, R Kuse, W Knauf, ...
Blood, The Journal of the American Society of Hematology 98 (5), 1326-1331, 2001
4712001
Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p
K Neben, HM Lokhorst, A Jauch, U Bertsch, T Hielscher, B van der Holt, ...
Blood, The Journal of the American Society of Hematology 119 (4), 940-948, 2012
4662012
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis
G Palladini, U Hegenbart, P Milani, C Kimmich, A Foli, AD Ho, MV Rosin, ...
Blood, The Journal of the American Society of Hematology 124 (15), 2325-2332, 2014
4652014
Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma
J Hillengass, K Fechtner, MA Weber, T Bäuerle, S Ayyaz, C Heiss, ...
J Clin Oncol 28 (9), 1606-1610, 2010
4542010
Suppression of T-cell functions by human granulocyte arginase
M Munder, H Schneider, C Luckner, T Giese, CD Langhans, JM Fuentes, ...
Blood 108 (5), 1627-1634, 2006
4462006
Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma
M Korbling, B Dorken, AD Ho, A Pezzutto, W Hunstein, TM Fliedner
4391986
Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity
M Munder, F Mollinedo, J Calafat, J Canchado, C Gil-Lamaignere, ...
Blood 105 (6), 2549-2556, 2005
4022005
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study
H Wandt, K Schaefer-Eckart, K Wendelin, B Pilz, M Wilhelm, ...
The Lancet 380 (9850), 1309-1316, 2012
3632012
The system can't perform the operation now. Try again later.
Articles 1–20